Vivos TherapeuticsVVOS
13F holders, Q2 2026 (June 30)22holders −2
1new positions
4sold out
$0.46avg. 13F price*
At the end of Q2 2026, 22 institutions reported holding Vivos Therapeutics Inc. (VVOS) in their 13F filings, down 2 from Q1 2026. 1 opened new positions and 4 sold out. The largest holders were Geode Capital Management, LLC ($39K), IHT Wealth Management, LLC ($35K) and Vanguard Capital Management LLC ($28K).
- Company
- Vivos Therapeutics Inc.
- CUSIP
- 92859E207
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $5K |
| Exits | 4 | $1.3M |
All 13F filers, Q1 2026 → Q2 2026: 82,122 shares bought and 1,373,799 shares sold, net −1,291,677 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 22 holders
| Geode Capital Management, LLC | 0.00% | Reduce -11.0% | 85,001 | $39K |
| IHT Wealth Management, LLC | 0.00% | Add +86.9% | 76,736 | $35K |
| Vanguard Capital Management LLC | 0.00% | Reduce -77.8% | 60,629 | $28K |
| Commonwealth Equity Services, LLC | 0.00% | No change | 42,500 | $19K |
| B. Riley Wealth Advisors, Inc. | 0.00% | No change | 38,066 | $19K |
| UBS Group AG | 0.00% | Add +254.5% | 39,154 | $18K |
| Centurion Wealth Management LLC | 0.00% | No change | 35,684 | $16K |
| BlackRock, Inc. | 0.00% | No change | 27,817 | $13K |
| State Street Corp. | 0.00% | No change | 24,922 | $11K |
| Sequoia Financial Advisors, LLC | 0.00% | No change | 24,000 | $11K |
| Vanguard Fiduciary Trust Co. | 0.00% | Reduce -24.0% | 23,432 | $11K |
| Northern Trust Corp. | 0.00% | Add +66.0% | 20,775 | $9K |
| Acorn Wealth Advisors, LLC | 0.00% | No change | 14,776 | $7K |
| Susquehanna International Group, LLP | 0.00% | New | 10,075 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -29.5% | 5,211 | $2K |
| Osaic Holdings, Inc. | 0.00% | No change | 1,143 | $516 |
| Signaturefd, LLC | 0.00% | No change | 547 | $249 |
| Blue Trust, Inc. | 0.00% | No change | 160 | $73 |
| Kozak & Associates, Inc. | 0.00% | No change | 49 | $24 |
| Global Retirement Partners, LLC | 0.00% | — | 23 | $10 |
| Morgan Stanley | 0.00% | No change | 7 | $3 |
| Royal Bank of Canada | 0.00% | No change | 4 | $0 |
"% of holder's portfolio" is VVOS's weight in each manager's 13F, not the share of Vivos Therapeutics Inc. the manager owns.